GURUFOCUS.COM » STOCK LIST » Technology » Software » Evolear AB (XSAT:EVOL) » Definitions » Investments And Advances

Evolear AB (XSAT:EVOL) Investments And Advances : kr0.00 Mil (As of Jun. 2024)


View and export this data going back to 2018. Start your Free Trial

What is Evolear AB Investments And Advances?

Evolear AB's Investments And Advances for the quarter that ended in Jun. 2024 was kr0.00 Mil.


Evolear AB Investments And Advances Historical Data

The historical data trend for Evolear AB's Investments And Advances can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Evolear AB Investments And Advances Chart

Evolear AB Annual Data
Trend Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Investments And Advances
Get a 7-Day Free Trial - - - - -

Evolear AB Quarterly Data
Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24
Investments And Advances Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

Evolear AB Investments And Advances Calculation

Investments And Advances includes all the non-current investments in affiliates, real estate, securities, etc.


Evolear AB Business Description

Industry
Traded in Other Exchanges
N/A
Address
Karolinska Institutet Science Park, Fogdevreten 2, Solna, SWE, SE-171 65
MyFirstApp Sweden AB formerly Obstecare AB is a provider of medical solutions on improving delivery care for both the mother and the healthcare provider. The company offers AFL monitoring and AFL measurement description.

Evolear AB Headlines